Bio
Medaica is a Nevada-based medical intelligence healthcare company building the platform and infrastructure for accessible, affordable cardiac care. Our mission is to eradicate preventable cardiac deaths, accounting for 80% of all cardiac fatalities. Our patented, FDA-cleared, AI-enabled heart exam platform allows patients to have an HCP-guided virtual exam or perform their own exam at home using our low-cost digital stethoscope; results are reviewed remotely by healthcare professionals supported by our AI diagnostic tools.
Beyond diagnostics, Medaica's acoustic biomarker platform is designed to support population-scale cardiac and pulmonary research, with the potential to reshape how we understand and predict heart disease at a societal level.
Our leadership team has built and scaled global technology platforms, including Symbian, the first global mobile OS, which shipped on over 600 million devices, TomTom, and foundational contributions to the Bluetooth standard. We bring that same platform-scale thinking to cardiac and pulmonary diagnostics.